On the 22nd, JNPMEDI and Kangwon National University Industry-Academic Cooperation Foundation entered into a partnership aimed at enhancing the bio-innovation startup ecosystem and advancing the global bio industry.
JNPMEDI is a Life Science RDC (Research, Development, and Commercialization) company established in July 2020, providing tailored solutions across all stages of business for clients in the pharmaceutical, biotech, and medical device industries. Through its clinical operations and data management solution, ‘Maven Clinical Cloud’, the company offers comprehensive support from business strategy, product development, and clinical research/regulatory approval to licensing out.
The partnership agreement was made to establish an organic collaboration framework, including the exchange of information and co-hosting of programs, to revitalize the bio-innovation startup ecosystem. The signing was attended by key figures such as Cheolseong Jang, Director of the Industry-Academic Cooperation Foundation, and Kwunho Jeong, CEO of JNPMEDI, along with representatives from both organizations.
Key aspects of the agreement include: ▲ Joint hosting and exchange of programs related to startups in the bio and medical device sectors ▲ Technical consulting and business exchange to promote the use of technologies held by both organizations ▲ Sharing of equipment and facilities, along with collaboration on R&D and exchange of experts and information.
Cheolseong Jang, Director of the Industry-Academic Cooperation Foundation, stated, "This agreement will help establish a strong linkage between universities and companies in the bio and medical device fields, contributing significantly to the development of regional industry-academic cooperation. We will continue working to strengthen the role of the university-industry collaboration network."
On the 22nd, JNPMEDI and Kangwon National University Industry-Academic Cooperation Foundation entered into a partnership aimed at enhancing the bio-innovation startup ecosystem and advancing the global bio industry.
JNPMEDI is a Life Science RDC (Research, Development, and Commercialization) company established in July 2020, providing tailored solutions across all stages of business for clients in the pharmaceutical, biotech, and medical device industries. Through its clinical operations and data management solution, ‘Maven Clinical Cloud’, the company offers comprehensive support from business strategy, product development, and clinical research/regulatory approval to licensing out.
The partnership agreement was made to establish an organic collaboration framework, including the exchange of information and co-hosting of programs, to revitalize the bio-innovation startup ecosystem. The signing was attended by key figures such as Cheolseong Jang, Director of the Industry-Academic Cooperation Foundation, and Kwunho Jeong, CEO of JNPMEDI, along with representatives from both organizations.
Key aspects of the agreement include: ▲ Joint hosting and exchange of programs related to startups in the bio and medical device sectors ▲ Technical consulting and business exchange to promote the use of technologies held by both organizations ▲ Sharing of equipment and facilities, along with collaboration on R&D and exchange of experts and information.
Cheolseong Jang, Director of the Industry-Academic Cooperation Foundation, stated, "This agreement will help establish a strong linkage between universities and companies in the bio and medical device fields, contributing significantly to the development of regional industry-academic cooperation. We will continue working to strengthen the role of the university-industry collaboration network."